Tirzepatide: a new low for bodyweight and blood glucose The Lancet Diabetes & Endocrinology CagriSema in Adults With or Without Diabetes REDEFINE 1 & 2 Cagrilintide 2.4 mg + Semaglutide 2.4 mg once weekly 20.4% weight loss (non diabetic) & 13.7% (T2D) Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica Retatrutide vs Mounjaro (Tirzepatide): Which is Better? Cagrilintide and semaglutide together drive record weight loss in global trial